Week 2: Depression and Anxiety Treatment

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall with Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/48

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No study sessions yet.

49 Terms

1
New cards

What was the monoamine hypothesis of depression?

TCAs and monoamine oxidase inhibitors seen as 1st gen of antidepressants, inhibit NA and 5HT3 neurotransmission. It gives a rationale for better drug development beyond these types.

2
New cards

Why was the monoamine hypothesis considered to be inadequate? (4)

1. No full explanation for antidepressant therapeutic action

2. No pathophysiology for depression

3. Doesn't explain why antidepressants take 2-3w to work

4. Doesn't explain why antidepressants are effective in other disorders eg. phobias

3
New cards

What is the HPA axis in depression?

Depression sees HPA overactivation:

1. High cortisol in saliva, plasma and urine

2. High CRH in CSF and limbic brain region

3. Large size + activity of pituitary + adrenal glands.

There is impaired -ve feedback.

4
New cards

What is a key counselling point in antidepressants?

Effects aren't seen immediately.

5
New cards

How do antidepressants affect the impaired HPA axis?

Enhance -ve feedback and decrease hyperactivity of HPA axis.

<p>Enhance -ve feedback and decrease hyperactivity of HPA axis.</p>
6
New cards

What is BDNF?

Brain Derived Neurotrophic Growth Factor - controls neurogenesis, development, dendritic growth, survival + maturation.

7
New cards

What is the neurotrophic hypothesis of depression?

Depression is associated with low BDNF levels. Antidepressants seek to alleviate the depressive behaviour and increase BDNF levels.

8
New cards

What are the neurotransmitters in depression and what do they control? (3)

1. 5-HT - Control anxiety, obsessions and compulsions. Low levels cause depression.

2. NA - Control alertness, anxiety, interest in life. Have a role in reward and stress.

3. DA - Control attention, motivation and reward. Low levels of tyrosine (precursor of DA) cause depression.

9
New cards

What factors do we need to consider for pharmacological mgmt? (4)

1. Adverse effect profile

2. Overdose toxicity

3. Interaction w/ other treatments

4. Cost

etc.

10
New cards

How do you treat mild depression in children and young people (<18)?

Psychological therapy - CBT.

11
New cards

How do you treat moderate-severe depression in children and young people? Outline the care plan. (4)

1. Psychological - for mild cases

2. Combined - add on SSRI (fluoxetine). - for moderate /severe

3. If resistant, alternative psychological therapy

4. If side-effects to fluoxetine - sertraline or citalopram. But fluoxetine has better clinical evidence.

12
New cards

How do you treat mild depression in adults?

1. Psychological intervention

2. NICE doesn't recommend drug treatment unless certain circumstances eg. PMH of moderate-severe depression.

13
New cards

How do you treat moderate-severe depression in adults?

Combined - psychological + anti-depressant.

14
New cards

What are the 3 main modes of action of anti-depressants?

1. Inhibit reuptake of neurotransmitter (5HT3)

2. Block receptor (prevent autoreceptors from inhibiting pre/s neurone)

3. Inhibit monoamine oxidase enzyme (on pre/s and cleft, its role is regulating neurotransmitter in pre/s by breaking it down in high amounts).

<p>1. Inhibit reuptake of neurotransmitter (5HT3)</p><p>2. Block receptor (prevent autoreceptors from inhibiting pre/s neurone)</p><p>3. Inhibit monoamine oxidase enzyme (on pre/s and cleft, its role is regulating neurotransmitter in pre/s by breaking it down in high amounts).</p>
15
New cards

List the 6 major classes of antidepressants.

1. TCAs.

2. MAOi (monoamine oxidase inhibitor).

3. SSRI (selective serotonin reuptake inhibitor).

4. SNRI (serotonin-noradrenaline reuptake inhibitor) eg. duloxetine, similar to SSRI.

5. NRI (noradrenaline-reuptake inhibitor) eg. reboxetine.

6. Mirtazapine.

16
New cards

How do TCAs work and what are their side-effects? (3)

Inhibit 5HT and NA uptake eg. amitriptyline, imiprapine.

1. Sedative properties (antagonise H1 receptor), which can stop early morning waking but also affect daily function

2. Anti-ACh side effects, i.e. inhibits parasympathetic NS (dry mouth, blurred vision)

3. CV effects since it also block other receptors (fatal in overdose)

17
New cards

What is the cheese reaction with MAOis? Give examples of drugs.

eg. phenelzine, tranylcypromine etc.

Inhibit MOA (which breaks down neurotransmitter), so tyramine (in cheese) isn't metabolised, entering circulatory system causing NA release from peripheral adrenergic neurones (⍺-1), causing a hypertensive crisis due to vasoconstriction.

Avoid tyramine-containing foods.

18
New cards

Which anti-depressants are first-line? Give examples and their mechanism.

SSRIs eg. citalopram, fluoxetine, sertraline.

Bind to transporter and block reuptake mechanism so neurotransmitters continue to exist. Has a favourable side effect profile and less toxic in overdose.

19
New cards

What is mirtazapine and how does it work? (2)

An atypical antidepressant that enhances NA and 5HT transmission. It targets:

1. block pre-synaptic ⍺-2 adrenoceptors (autoreceptors) which usually block NA release.

2. block pre-synaptic 5-HT2 receptors, which usually block 5-HT release.

20
New cards

What is the theory for potential delay for clinical effect? What happens with continuous use of antidepressants?

A theory that explains the delayed clinical response for anti-depressants. EG. SSRIs bind to the reuptake transporters, which activate autoreceptors on pre/s neurone, blocking release of 5-HT into the cleft for a period of time.

W/ continuous antidepressant usage, Autoreceptors become desensitised, reinstating release of neurotransmitter.

<p>A theory that explains the delayed clinical response for anti-depressants. EG. SSRIs bind to the reuptake transporters, which activate autoreceptors on pre/s neurone, blocking release of 5-HT into the cleft for a period of time.</p><p>W/ continuous antidepressant usage, Autoreceptors become desensitised, reinstating release of neurotransmitter.</p>
21
New cards

What is a theory for BDNF explaining clinical effect delay?

Antidepressants elevate BDNF levels, but it takes time for them to be expressed which can explain the clinical effect delay.

22
New cards

Potential delay of clinical effects

2 theories

  • Monoamine Hypothesis: Antidepressants increase neurotransmission but mood improvement is delayed.

  • Neurotrophic Hypothesis:

    • Depression reduces brain-derived neurotrophic factor (BDNF) levels.

    • Antidepressants elevate BDNF, promoting neurogenesis and synaptic growth.

23
New cards

What is BDNF

Brain Derived Neurotrophic Factor regulates neurogenesis, development, dendritic growth, survival and maturation.

24
New cards

What does the neurotrophic hypothesis of depression propose?

  • Proposes that depression is associated with reduced brain BDNF levels

  • Antidepressant treatments alleviate depressive behaviour and ­ BDNF levels

25
New cards

Depression often involves negative emotional biases

  • Negative views of the self, others, and the world.

  • Learned helplessness contributes to inactivity and reduced social engagement

26
New cards

What characterises bipolar disorder? What is its incidence?

A cycle between depressed mood and mania.

Depressed mood - 2w+ with core symptoms (low mood and loss of interest), along with 4 other symptoms.

Mania - elevated mood, increased energy, incomprehensible speech, racing thoughts and poor concentration.

1st episode is seen before age 30, peak incidence between 15-19 years.

27
New cards

What is Euthymia

substantial intervening periods in which mood is okay

28
New cards

How can you confirm a BPD diagnosis?

Specialist mental health professionals will diagnose it and make pharmacological recommendations. Has a complicated differential diagnosis.

29
New cards

How can you manage mania in BPD for acute and long-term purposes?

Acute: Antipsychotics (eg. risperidone, haloperidol, olanzapine) and lithium (mood-stabilising drug).

Longer-term: Lithium, valproate (anti-epileptic), quetiapine.

30
New cards

neagtives for Lithium/valporate

  • Lithium/valporate for longer term mania and bipolar

    • This requires more frequent blood testing

    • Narrow therapeutic range

31
New cards

How do you manage bipolar depression? (4)

1. SSRI fluoxetine + olanzapine

2. Quetiapine alone

3. Olanzapine alone (all anti-psychotics)

4. Lamotrigine alone (anti-epileptic/anti-convulsant).

Should check guidelines if pt. is taking lithium.

32
New cards

How do you monitor therapeutic doses of lithium?

Narrow TW (0.5 mmol/L). If you exceed by 1mmol/L, there is toxicity and going subtherapeutic renders it ineffective.

Toxicity can cause diarrhoea, drowsiness, weakness, convulsions etc.

<p>Narrow TW (0.5 mmol/L). If you exceed by 1mmol/L, there is toxicity and going subtherapeutic renders it ineffective.</p><p>Toxicity can cause diarrhoea, drowsiness, weakness, convulsions etc. </p>
33
New cards

What is generalised anxiety disorder?

Worry for >6mo disproportionate to stress, w/ insomnia, muscle tension w/ headaches, backaches and autonomic physical symptoms (palpitations, HR).

34
New cards

What are the causes of anxiety? (6)

1. Genetics (1º relative)

2. Neurochemical + neurohormonal (HPA axis - ↑cortisol)

3. Environmental

4. Drugs + meds

5. Physical and mental health

6. Diet

35
New cards

What are the 4 aspects of neurobiology regarding GAD (Generalised Anxiety Disorder)?

1. Neuroimaging

2. Genetics (nature v nurture)

3. Neurotransmitters

4. Neuroendocrine (HPA)

36
New cards

Explain the neuroanatomy of anxiety

The amygdala = triggers fight/flight + acute threat response

The bed nucleus of the stria terminalis = handles uncertainity + chronic threat response

Frontal lobe = uses logic to regulate emotional centres

37
New cards

What do the prefrontal cortex and motor cortex control?

Prefrontal: intellectual, emotional behaviour (suppresses aggression). Connected to amygdala.

Motor: contains premotor and primary motor cortex.

<p>Prefrontal: intellectual, emotional behaviour (suppresses aggression). Connected to amygdala. </p><p>Motor: contains premotor and primary motor cortex.</p>
38
New cards

How does GAD appear in neuroimaging?

Decreased connectivity between amygdala and prefrontal cortex.

39
New cards

How is GAD linked to genetics?

Genes - 30-50%.

Environment - 50-70% (eg. trauma, stressful home life contribute more than genetics).

40
New cards

What are the neurotransmitters associated with GAD? (4)

1. GABA - GABA(A) is downregulated so less inhibition (more excitation), treated with GABA agonists.

2. 5-HT - SSRIs have efficacy for GAD (↑serotonin levels help)

3. CRH - Unsuccessful clinical trials.

4. Neuropeptides - hypersensitive to CCK agonists. Antagonists were unsuccessful in trials.

41
New cards

How is GAD linked to the HPA axis?

↑HPA axis, ↑cortisol, ↑NA and A. Overstimulation of SNS.

<p>↑HPA axis, ↑cortisol, ↑NA and A. Overstimulation of SNS.</p>
42
New cards

How do you treat the autonomic symptoms of GAD? What is a counselling point with the drug?

i.e. SNS overactivity (eg. palpitations and tachycardia).

Target with β-blockers (propranalol) which reduce autonomic effect.

Note: don't withdraw abruptly to prevent rebound effects.

43
New cards

How do you treat the anxiety symptoms of GAD? (3)

1. Psychological interventions

2. Offer SSRI (1st line is sertraline).

3. Do not offer benzodiazepine (anxiolytic) except for short-term use during a crisis. They target GABA(A) but can cause dependence and tolerance issues.

44
New cards

What are benzodiazepines (BDZ) used for? (6)

Target GABA(A) receptor complex.

1. Muscle relaxation

2. Insomnia (anxiolytic effect for hypnosis)

3. Pre-meds (treat anxiety before major surgery)

4. Epilepsy

5. Alcohol withdrawal

6. Anxiety

45
New cards

What are some other Pharmacological Treatments for anxiety disorder

  • Pregabalin (GAD; risk of misuse). - risk if taken with opioids/alcohol , helpful for short term

  • Propranolol (physical symptoms by the SNS of anxiety; toxic in overdose).

  • Antipsychotics (PTSD re-experiencing symptoms).

  • Clomipramine (OCD).

  • Buspirone (GAD, slower onset). - causes Gi issue

  • Quetiapine (sedation, weight gain)

46
New cards

How are BDZs classified? (3)

By their t-1/2.

1. Short-acting: less than 5hrs. For hypnosis purposes.

2. Short-intermediate: 5-24hrs.

3. Long-acting: >24hrs.

The classification influences their use eg. hypnotic drugs have a shorter t-1/2.

47
New cards

Explain the GABA(A) receptor, its subunits and what binds. (4)

GABA has 5 units - 2 ⍺, 2 β and 1 gamma.

1. BDZ bind between ⍺ and gamma subunits.

2. GABA binds between ⍺ and β subunits.

3. Alcohol will bind to ⍺ subunits.

4. Neurosteroids (anaesthetics) and barbiturates bind to β subunits.

Binding opens Cl- ion pore, causing Cl- influx.

<p>GABA has 5 units - 2 ⍺, 2 β and 1 gamma. </p><p>1. BDZ bind between ⍺ and gamma subunits. </p><p>2. GABA binds between ⍺ and β subunits. </p><p>3. Alcohol will bind to ⍺ subunits. </p><p>4. Neurosteroids (anaesthetics) and barbiturates bind to β subunits. </p><p>Binding opens Cl- ion pore, causing Cl- influx.</p>
48
New cards

Explain the MOA of BDZs. (3)

1. BDZs are +ve allosteric modulators on the GABA(A) complex (btwn ⍺ and gamma subunits). Cause a conformational change that allows GABA to bind (btwn ⍺ and β subunits).

2. When GABA binds, receptor undergoes another conformational change, opening Cl- channel pore.

3. Causes Cl- influx into neurone, causing hyperpolarisation → inhibiting neurotransmission.

Promotes inhibition of excitability.

49
New cards

What should you prioritise treating with anxiety and depression?

The depression first, then anxiety symptoms.